These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 14026697)

  • 1. Decarboxylase inhibitors as hypotensive agents.
    DELGADO JN; COSGROVE EP
    Tex State J Med; 1963 Jun; 59():529-30. PubMed ID: 14026697
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANTIHYPERTENSIVE ACTION OF A DOPA-DECARBOXYLASE INHIBITOR: METHYLDOPA].
    BENZI G
    Farmaco Prat; 1963 Dec; 18():688-93. PubMed ID: 14121022
    [No Abstract]   [Full Text] [Related]  

  • 3. Decarboxylase inhibitors in the treatment of hypertension.
    BREST AN; MOYER JH
    Am J Cardiol; 1962 Jan; 9():116-9. PubMed ID: 13872878
    [No Abstract]   [Full Text] [Related]  

  • 4. Actions of the decarboxylase inhibitor, alpha-methyl-3,4-dihydroxyphenylalanine, in the dog.
    GOLDBERG LI; DACOSTA FM; OZAKI M
    Nature; 1960 Nov; 188():502-4. PubMed ID: 13706461
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine oxidase and decarboxylase inhibitors as antihypertensive agents.
    GILLESPIE L; SJOERDSMA A
    Med Clin North Am; 1961 Mar; 45():421-8. PubMed ID: 13705342
    [No Abstract]   [Full Text] [Related]  

  • 6. Competitive inhibition of 3, 4-dihydroxyphenylalanine (DOPA) decarboxylase in vitro.
    HARTMAN WJ; AKAWIE RI; CLARK WG
    J Biol Chem; 1955 Oct; 216(2):507-29. PubMed ID: 13271331
    [No Abstract]   [Full Text] [Related]  

  • 7. A rapid method for the determination of dihydroxyphenylalanine decarboxylase in animal tissues.
    DIETRICH LS
    J Biol Chem; 1953 Oct; 204(2):587-91. PubMed ID: 13117832
    [No Abstract]   [Full Text] [Related]  

  • 8. [CLINICAL EXPERIENCES WITH ALPHA-METHYL-DOPA, A DECARBOXYLASE INHIBITOR].
    RIPKA O
    Cas Lek Cesk; 1965 Feb; 104():173-5. PubMed ID: 14308252
    [No Abstract]   [Full Text] [Related]  

  • 9. [DECARBOXYLASE INHIBITORS IN THE THERAPY OF ARTERIAL HYPERTENSION (L-ALPHA-METHYLDOPA)].
    BUONINCONTI R; JACONO A; VITALE P
    Minerva Med; 1963 Oct; 54():3169-74. PubMed ID: 14104505
    [No Abstract]   [Full Text] [Related]  

  • 10. Are dihydroxphenylalanine decarboxylase and 5-hydroxytrptophan decarboxylase individual enzymes?
    ROSENGREN E
    Acta Physiol Scand; 1960 Aug; 49():364-9. PubMed ID: 13743456
    [No Abstract]   [Full Text] [Related]  

  • 11. [METHYLDOPA AND DECARBOXYLASE INHIBITION].
    OFFERHAUS L; MUEHLEN AC; DE VRIES LA
    Ned Tijdschr Geneeskd; 1964 May; 108():966-8. PubMed ID: 14168782
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydroxyphenylalanine decarboxylase; preparation and properties of a stable dry powder.
    SCHALES O; SCHALES SS
    Arch Biochem; 1949 Nov; 24(1):83-91. PubMed ID: 15400365
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology of newer anthypertensive agents, monoamine oxidase and decarboxylase inhibitors, bretvlium tosvlate, and guanethidine.
    GILLESPIE L
    Ann N Y Acad Sci; 1960 Oct; 88():1011-20. PubMed ID: 13705343
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of alpha-methyl DOPA and some other decarboxylase inhibitors on brain 5-hydroxtryptamine.
    DRAIN DJ; HORLINGTON M; LAZARE R; POULTER GA
    Life Sci (1962); 1962 Mar; 1():93-7. PubMed ID: 13887715
    [No Abstract]   [Full Text] [Related]  

  • 15. [A method for determining aromatic amino acid decarboxylase].
    Streffer C
    Biochim Biophys Acta; 1967 May; 139(1):193-5. PubMed ID: 6033470
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new hypotensive drug: a-methylDopa].
    URBINATI GC
    Clin Ter; 1962 Oct; 23():669-77. PubMed ID: 13995460
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent acquisitions in the field of hypotensive drugs: the place of DOPA-decarboxylase inhibitors].
    Wermuth CG
    Therapie; 1965; 20(6):1569-78. PubMed ID: 5323032
    [No Abstract]   [Full Text] [Related]  

  • 18. Design and synthesis of heterocyclic malonyl-CoA decarboxylase inhibitors.
    Cheng JF; Chen M; Liu B; Hou Z; Arrhenius T; Nadzan AM
    Bioorg Med Chem Lett; 2006 Feb; 16(3):695-700. PubMed ID: 16257202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic application of an inhibitor of histidine-decarboxylase].
    THIERS H; MOULIN G; ROUHANI A
    Lyon Med; 1963 Mar; 209():689-94. PubMed ID: 13980982
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery of potent and orally available malonyl-CoA decarboxylase inhibitors as cardioprotective agents.
    Cheng JF; Huang Y; Penuliar R; Nishimoto M; Liu L; Arrhenius T; Yang G; O'leary E; Barbosa M; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
    J Med Chem; 2006 Jul; 49(14):4055-8. PubMed ID: 16821767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.